Home/Filings/4/0001250853-16-000132
4//SEC Filing

Lion Biotechnologies, Inc. 4

Accession 0001250853-16-000132

$IOVACIK 0001425205operating

Filed

Mar 14, 8:00 PM ET

Accepted

Mar 15, 7:09 PM ET

Size

5.6 KB

Accession

0001250853-16-000132

Insider Transaction Report

Form 4
Period: 2016-03-11
Bender James G.
Vice President, Manufacturing
Transactions
  • Award

    Stock Option (right to buy)

    2016-03-11+30,00030,000 total
    Exercise: $5.05Exp: 2026-03-11Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]The option will vest as to 10,000 shares on March 11, 2017, and the remaining 20,000 shares will vest quarterly over the next two years after March 11, 2017, provided the Reporting Person is still providing services to the Issuer on the respective dates.

Issuer

Lion Biotechnologies, Inc.

CIK 0001425205

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001425205

Filing Metadata

Form type
4
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 7:09 PM ET
Size
5.6 KB